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Backgmund. Dierpat thrombolytic regimens for acute mya- 
cardial infarctian proved ta be equally elfeetiw in brge Seae 
mertality LriNo dapite siga&w dSrence3 in their etXcaey with 
respmt o ear!y infnrct.relsted wssel patency 9s shown in smaller 
ao~pllic ‘As. 
Ma!wds. Patimtr from few Gewan multic?!!!?r studies of 
tbmmbolysis in acute mywardiat i&r&o were retmwclively 
evaluated. Of 939 palienb ni* acute myocardiat infarction 
(duration of symptoms <6 h) treated sitb thwmbolyais. 901 
(96.6%) had aa m&gram of tbe b&ret-related artery 90 min 
atIer tbc inltlatbo of tbmmbol~tic therapy. The prfusion status 
was graded acsxrtliog to the Tbmmbotysb io Myocardial Infarc. 
t&o (TIMI) study criteria. 
The efficacy of thrombolytic treatment for acute myocardial 
infarction was evaluated in several studies by angiographic 
assessment of early patency of the infarct-related vessel 
because reperfusion was thought to be the most important 
mechanism of thrombolysis to improve survival. It has been 
shown that infarct vessel patency 90 min after the initiation 
of thmmbolysir varies between 65% and 75% wth different 
thrombolytic agents and dose regimens U-t I). Recently. we 
(12.13) demonstrated an increased early patency rate >80% 
with front-loaded infusion of recombinant tissue-type plas- 
minogen activator @t-PA). In contrast. large scale clinical 
trials (E-17) failed to demonstrate a difference in mortality 
assc&ted with diEwent thrombolytic ireatments. raising 
the question whether early patency of the infarct vessel had 
a major intluence on the outcome of myocardial infarction. 
Since the Thromboiysis in Mywxdial Infarction (TIMi) 
study (3). an infarct-related vessel has commonly been 
regarded as patent when complete anterogade tilling has 
heen demonstrated angiographically, even ifthe ante:ograde 
Row is obviouslv comoromised (TIMI aerfosion gnde 2). It 
was recently cldmed~(lD that this &tial perfusion may 
represent a mostly occluded. but not an open. infLy! artery. 
if this is correct. the traditional definition of iofarct vessel 
patency would significantly overestimate the elcacy of 
thrombolysis. and the possible impact of early iofwct vessel 
patency on clinicd outcome would be masked by an angio- 
graphic mtsmterprelation offunc!iona!ly occluded vessels as 
being open. 
Therefore. we retrospectively analyzed the aogiowphic 
results in SMl patients fmm four cooperative studies with 
similar prow& 111-14). The pat& were treated with 
different thrombolytic agents and dose regimens. However, 
the an of this analysis wes not to assess the diffwences 
among various thrombolylic treatments. but to examine 
possible correlations between the pertusion statas of infarct- 
related vessels and the short-term clinical outcome of the 
patients. 
Methods 
Study protocol and treatment. Patients aged 25 to 75 
years with acute myocsrdial infarction diagnosed by typical 
clinical symptoms of >30 min and <6 h duration and by ST 
segment elevations in the electrocardiogram (23 mm in two 
precordial or r2 mm in two limb leads) were included in four 
multicentersuldies oftbromixdyiic treatment(ll-14). Glthe 
954 patients whe entered the studies, 290 were treated with 
front-loaded n-PA (I5 mg bolus injection, XI mg over 30 min. 
35 mg over60 min), 124 with 70 mgof rt-PAWmin. 210 with 
a bolos injecrion of 30 mg of anisoylated plasminogen 
slreptokinare activator complex (APSAC). 121 with uroki- 
nase {IS-million U bolus injection and I.5 million ll over 
W min) and 194 with bolus injections of r-PA of 10 million U 
(a = 431, 15 million U (a = IW) or IO million U and analber 
5 million U alter 30 min (a = 51). Fifteen eatients received 
no thmmbolytic freatment b&use of &thdrawal of in- 
formed consent or detection of a contraindication after study 
entry. 
The common main end point of the four studies was the 
Wmin patency of the infarct-related artery as determined by 
angiography. Secondary end points were reocclusions as 
documented by control angiograms after 24 to 48 h and 
before hospital discharge (day I4 to 21). in-hospital clinical 
events (especially death and &far&m) and adverse ffects 
of the thrombolytic treatment. 
Each coronary angiogram was evaluated centrally by at 
least two independent observers. The perfusion of the in- 
farct-related arlery was graded according 10 the Thrombol- 
ysis in Myocardial Infarction (TIMI) study criteria (3). 
Statistics. In this retrospective analysis, the IS patients 
without thrombtiiytic lherapy were excluded. None of 
these patients died in rhe hospital and none had utber 
serious events. Statistical tests for univariate differences 
between groups were perfomed with the chi-square test 
or analysis of variance (ANOVA). Multivariate analysis for 
predicrors of death was performed with backward stepwise 
logistic regression analysis. The regression equation used 
was IogW-P)=b,tb,x,tb,x,t . . b,x,, where P is the 
probability of death, bo is the intercept and b, through b, are 
the regression weights of variables x1 to xn. The following 
variables were tested for possible correlation with short- 
term mortality in the univariate and multivariate analyses: 
age, gender, thrombolytic regimen. duration of symptoms 
before the start of thrombolysis. perfusion status of the 
infarct-related vessel on the Wmin angiogram. acute core. 
nary inlerwntions (generally augioplasty) and early raocclu- 
sion of the infarct vessel. All statistics were computed with 
the CSS QrW+W” by STAT-SOFT. Data are reported as 
mean value ? SD unless otherwise mdicakd. 
ReSSltS 
Patients and in-hospital events. The mean age of the 939 
Pafienfs ansiyzed here was 57 -r 10 years; t63 Qetients 
(17.4%) were female. The duration of symptoms to the start 
of thrombolytic therapy was 163 r 70 min. The maximal 
serum activity of creatine kinase was 1,062 f 775 Uniter; 398 
patients (42.4%) had an anterior myocardial infarction. 
During: the ho&al SW (un!i! 21 days after the acute _ . . 
infarction), there were 43 deaths (4.6%). Nineteen patients 
died in intractable cardiac failure or shock, nine as a result of 
reinfarction and nine of other cardiac causes (pericardial 
tamQOaade in two, venrriwlar rupture in two. sudden death 
in two, complicati0r.r of coronary angioplasty in two, peri- 
operative death in out). Six patients died of noncardiac 
causes (cerebral bleeding in three, ischemic stroke in two, 
and retroperitoneal bleeding in one). Definite reinfarction, BE 
diagnosed by chest pain accompanied by newly developed Q 
waves or a signilicaat increase in cardiac enzyme levels, or 
both. was encountered in 5.5 patients. 
An&graphic mulls. Of 939 patients, 907 (%.6%) had a 
9C-min aagiogram of the infarct-related vessel; 860 (91.6%) 
and 750 (79.9%) had control angiograms after 24 to 48 h and 
14 to 21 days, respectively. The infarct-related artery was 
the left anterior descending coronary artery in 395 patients 
(42.1%). the right coronary artery in 3% (42.2%) and the left 
Grcumflex coronary artery in 124 (13.2%). In I2 patients, the 
infarct vessel could not he determined angiographically. The 
overall patency rate of the infarct arteries (TIM1 perfusion 
made 2 or 31 was 75.4% at 90 min. 87% at 24 to 48 h and 
i5.6% after i4 to 21 days. 
One hundred thirty-;ight patients underwent angioplasty 
of the infarct-related vessel immediatelv after the 90min 
an&ram; no addirional interventions &re performed be- 
fore. In Ihe later studies (K-14). the investigators were 
requested to perform angioplasty only in patients with a 
persistently occluded infarct verse1 (TIMI gmde 0 or 1) or if 
clinical signs of ischemia were present. In these studies, 
therefore, only 86 (12.4%) of 694 patients had acute an& 
plasty. Twen&three of these i&ventions were performed 
in open infarct vessels (IO TIM1 made 3 and 13 TIM1 made 
2). in the earlier German Adivator Urokinase <tudy 
(GAUS) (II), acute angioplasty was used more frequently 
(52 l21.2%1 of 245 patients) and in 17 of these patients, the 
infarct vessel was already open before angioplasty (TIM1 
grade 3 perfusion in IO patients and TihU grade 2 perfusion 
in loo the Wmin aagiogram). Overall, the success rate of 
these acute angioplasty procedures was 7%. Thirty-seven 
patients had orher interventions immediately after Ihe 90. 
min angiogmm (guide wire maaipularion or additional throm- 
bolysis); 22 of these interventions were successful. 
Angiegraphically documented reocclusion of the iafarct- 
related vessel was seen within the 1st 48 h in 54 patients: this 
group COmQriSes 6% of%7 patients with a Wmin WiOgIam 
and 7% of 77s palients with an open artery (by thrombolysis 
or additional intcrverd;ons) at the end of the 9Omia angic- 
gram. Fourteen of these early reocciusions occurred after 
coronary angioplesty. Lx@ &clusion (after the second 
an&ram) was documented angiograQhic& in 52 patients; 
this group comprises 5.7% of 907 Q&MS with a %I-min 
Figure I. in-hospital mortality in patients with an occluded ~niarct- 
related vessel on the 90-M angiogmm (O/t1 and with pnial I!) and 
complete 13) reperfurion. The group diLrenccr ore ra~mkant bv 
multivariate analysis Ip c 0.011. N denotes the number ofpatxws m 
either group. TIM1 = Thmmbolysis in Myucanhrl Inlareuon. 
angiogram and 1% of 146 patients with an open artery on the 
control angiogram after 24 to 48 k. In the tolal group of 106 
patients with early or late angiographtcully dvcumenred 
reccclusiort, 26 patients had definite reinlwztion and 2 
patients died. 
Impact of early peefusiun status on outcome. Of the 43 
patients who died in the hospital. 4 died in cardiogenic phock 
without a W-min angiogtnm of the infarct-related vessel. 
However. three of these four patients had an angiognm 
obtaixd 60 mitt after the start of tkrombolysis that showed 
an occluded infarct artery. The fourth patient died within 
SO min after the start of thrombolytic therapy without any 
angiogram. 
In the remaining pctients. the perfusion grade on the 
Wmin angiogrum proved to be a significant predictor uf 
in-hospital mortality (Fig. Il. Complete early reperfusion of 
Ike infarct-related artery was associated with =6lD lower 
in-hospital mortality rate than that observed in patients with 
an occluded vessel. In patients with onb partial perfusion of 
the infarct vessel (TIM1 perfusion grade 2 at 90 mini. the 
mortality rate was similar to that in patients with comple:e 
occktaion. 
In univariate analysis. age and gender were also signifi- 
cant predictors of mortality. Mortality was 1.3% in patients 
<SO years ofage, 2.4% in those aged 50 to60 years and 8.3% 
in patients >&I years old (p < 0.001. ANOVA). The mar. 
talky rate was 8.6% in women compared with 3.7% in tneu 
(p = 0.013, chi-square analysis). However, gender was not a 
significant predictor of mortality in mukivariatc analysis. 
The reason may be thst the female patients were signiticandy 
older than the mule patients 161.4 2 9.6 years vs. 56.5 ? 9.Y 
years. p < 0.0011. In multivariate analysis. age. early perfu- 
sion grade and infarct-related vessel were significant inde- 
pendent predictors of mortality. Patients with the left ante- 
rior descending coronary artery as infarct vessel had a 
mortality rate of 5.8% versus 3.8% and 3.2%. respectively, 
in patients with the right and left circumflex coronary artery 
as the infarct vessel. These differences were not significant 
in the univariate chi-square test, presumably because the 
patency rate of the left anterior descendingartery was higher 
than that of the left circumflex or rigkt coronar) artery 
tEO.YZ vs. 71.2% and 70.6%. respectively. p < O.Ol!. an 
effect that could have partially masked the otherwise nega- 
live impact of the left anterior descending artery as tke 
iniarct xssrl. 
In patients with complete early reperfusion, the cause of 
death ~85 more commonly reinfaraion, whereas patients 
with an occluded or an only purtially perfused infarct-related 
vessel died more oRen from intmctuble heart failure without 
reinfurction or from other cardiac causes (Table I). No 
ditfwences were seen in the arterial blood pressure or heart 
rate in vatients with occluded or uwtiallv or comp!etelv 
perfused infarct vessels on the W-mkt ang&ratn. 
Reinfarction wus encountered in 35 (6.2%) of 561 patients 
with complete reperfusion on the !W-min angiogram. 10 
(4.S%,) of 224 patients with an ocduded artery and 8 (6.6%) 
of i?? patients with partial perfusion (p = NS tor ulk. 
Discussion 
Homogeneity d study gmnp. In this retrospective analy- 
ris. we included patients from four multicenter studies 
(1 I-14). which leads to the question, do these patients fomt 
a homogeneous group? The most important difference 
among the studies was the tkmmbdytic treatrnunt. The four 
studies used five diRerent treatment regimens and four 
ditTerent drugs: however, the differences in mortality among 
these treatment groups were not statistically rigniticant In 
eoivatiate or multivariate analyses. The protucols of the four 
studies were similar wtih respect to inclusion criteria and the 
main study end point, natnet]. perf!&m sWts of the 
infarct-related artery 90 min after the initiation of thrombo- 
lytic therapy. The central evaluation of the ungingrums was 
performed by the same group of only three investigators, and 
only 3.4% of the Wnin angiograms of the infarct vessel 
were missing. The patient groups in the four studies did not 
differ s~gniiicantly with respect to age, gender distribution, 
incidence of anterior myacardial infarction, maximal ~emtn 
creatine kinase activity or in-hospital mortality. The earlier 
GAUS study (11) differed from the more recent r&PA- 
APSAC Patency Study (TAPS) (13) and German Recombi- 
nant Plasminoaen Activator GRECO) study (14) with re- 
spect to the humtion of symptoms until the start of 
thrombalysis (I80 f 70 vs. 157 * 69 min) and there were 
more acute coronary interventions. The duration of symp 
tams, however, was not significantly related to short-term 
outcome in these studies; it was 172 * 51 min for patients 
who died in the hospital and 162 ? 71 mitt for survivors (p = 
0.385). In GAUS study (ll), Zl.Z%ofthe patients underwent 
angioplasty immediately after the 90.min angiogram com- 
pared with onlv 12.4% of ustients in the more recent studies. 
This higher incidence ofkarly interventions may aEect the 
incidence of reocclusion, but there was no significant asso- 
ciation between early angioplasty and survival in these 
studies. Thus, the patients in the four studies form a suffi- 
ciently homogeneous group, although not ideal or prospee- 
lively defined, with respect to the factors analyzed in this 
report. 
Early perfusion as P predictor of mortality. The main 
result of our analysis is that early complete repctfusion of 
the infarct-related vessel is associated with a significantly 
lower in-hospital mortality rate than that of patients with an 
occluded infarct vessel on the !J&tnin angiogram. This asso- 
ciation is statistically highly significant even after correction 
for age, gender and the infarct vessel involved. We con- 
clude, therefore, that the early perfusion status of the infarct 
vesseI is an independent predictor of short-term outcome of 
myocardial infarction. Of the four patients who died without 
a 90.min angiogram, three had an occluded infarct vessel 
M) min after the start of thrombolysis. Thus, even these 
enctoded patients more than confirm the main result of the 
analysis. 
Lack of elfwl of rencelusiun on mtily. In contrast to 
early patency, angiographically documented reocdusion of 
infarct-related vessels had no influence on monality. The 
reason may be that most of the patients with angiographi- 
tally documented reocclusion had no definite reinfarction. 
None of the patients with clinically asymptomatic rcoccIu- 
sion died. In an earlier study of reperfusion as a determinant 
of survival, Sheehan et al. (19) demonstrated a significantly 
improved long-term survival in 134 patients with sustained 
reperfusion compared with that in 31 patients with unsuc- 
cessful thromholysis or reocclusion. In their study, how- 
ever, the early perfusion status alone was not a significant 
predictor of survival. Recently, Brodie et al. (20) reported 
that infarct vessel patency was the most important predictor 
of in-hospital survival after direct coronary angioplasty for 
acute myocardial infarction. In contrast to our observation, 
Ohman et al. (21) in a compilation of the Thrombolysis and 
Angioplasty in Myocardial Infarction (TAMI) experienx 
reported a significantly increased in-hospital mortality rate 
cf II% in patients with versus 4.5% in those without 
reocclusian of the infarct vessel ufter initially successful 
thmmholysis. One major difference between their study and 
ours is that a much larger proportion of patients in the TAM1 
studies underwent angioplasty in the acute period, a factor 
that might influence the incidence as well as the clinical 
consequences of reoalusion. Moreover, early reocclusion 
in OCR studies was restricted to the time interval between the 
first and second angiogram. which was performed after 2 
days at the latest, whereas in the TAM1 studies control 
angiography was performed at a median of I days. There- 
fore, the patients with reocclusian from the TAM1 compila- 
tion (21) cannot easily be compared with the patients with 
reucclusion in our studies. 
Leek of relatiin of in-hospital reinlarction to e&y pe& 
stun The incidence of in-hospital reinfarction was not sig- 
nificantly related to the early perfusion status; there was 
only a trend to more reinfarction in patients with early 
rewrfusion in our studies. Six of IO reiufarrtions in patients 
with failed thrombolysis occurred after rescue angibplasty: 
in the remaining 4 cases it is likely that spontnneous reper- 
fusion occurred after XhJ min and reocclusion followed 
later. 
TIM1 grade 2 versus TIMI gawk 3 prfwiun. An impor- 
tant observation derived from this analysis is that patients 
with only partially perfused infarct vessels (TIM1 grade 2) 
did not fare better than those with an occluded vessel. This 
finding confinns the suggestion that TlMI grade 2 perfusion 
-epresents a mostly occluded infarct-related vessel (18). 
Therefore, the traditional interpretation of TIMI grade 2 
perfusion as successful treatment significantly overestimates 
the efficacy of thrombolysis for acute myoardii infarction. 
Because the in-hospital mortality rate is reduced only in 
patients with complete early reperfnsion, only TIhU grade 3 
perfusion of the infarct vessel should be regarded as SUE- 
cessfid thrambolysis. Using this criterion. the early prfu- 
sion status of the infarct artery might be used as a surrogate 
end win1 for short-temt monalitv data in future studies of 
thrnkmlysis in myncardial inf&tion. 
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